Potential approaches to reverse or repair renal fibrosis (Q38186986)

30 August 2017

Potential approaches to reverse or repair renal fibrosis (English)

1 reference

30 August 2017

Desiree Tampe

1

1 reference

PubMed ID

24514753

30 August 2017

Michael Zeisberg

series ordinal

2

1 reference

PubMed ID

24514753

30 August 2017

language of work or name

English

0 references

publication date

11 February 2014

1 reference

Nature Reviews Nephrology

30 August 2017

1 reference

30 August 2017

10

1 reference

30 August 2017

226-237

1 reference

30 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2014.14

30 August 2017

0 references

cites work

Chronic progressive renal disease: rate of change of serum creatinine concentration

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

A simple tool to predict end-stage renal disease within 1 year in elderly adults with advanced chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Regression of diabetic complications by islet transplantation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Correlations between relative interstitial volume of the renal cortex and serum creatinine concentration in minimal changes with nephrotic syndrome and in focal sclerosing glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Influence of microvascular endothelial cells on transcriptional regulation of proximal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Matrix as a modulator of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Toward a unified theory of renal progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Methylation determines fibroblast activation and fibrogenesis in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Origin and function of myofibroblasts in kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Evidence that fibroblasts derive from epithelium during tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Tubulointerstitial injury and the progression of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Biomarkers for epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Isolation of renal progenitor cells from adult human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Microvascular disease precedes the decline in renal function in the streptozotocin-induced diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Beneficial effects of antioxidant vitamins on the stenotic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Peritubular capillary regression during the progression of experimental obstructive nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Increased cellular senescence and vascular rarefaction exacerbate the progression of kidney fibrosis in aged mice following transient ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Thrombospondin-1 short hairpin RNA suppresses tubulointerstitial fibrosis in the kidney of ureteral obstruction by ameliorating peritubular capillary injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

The immune system and kidney disease: basic concepts and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Macrophage diversity in renal injury and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Nephrogenesis is induced by partial nephrectomy in the elasmobranch Leucoraja erinacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Regrow or repair: potential regenerative therapies for the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Renal recovery after injury: the role of Pax-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Pax2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Wnt/beta-catenin signaling regulates nephron induction during mouse kidney development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Bone morphogenetic protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Expression and characterization of a human BMP-7 variant with improved biochemical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Addition of endothelial progenitor cells to renal revascularization restores medullary tubular oxygen consumption in swine renal artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Parthenogenetic stem cells for tissue-engineered heart repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

DNA demethylation dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-β mediated renal fibrosis in obstructive uropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Non-hydroxamate histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

The metabolic syndrome and chronic kidney disease in U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

ALTITUDE Trial and Dual RAS Blockade: The Alluring but Soft Science of the Surrogate End Point

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Risk for end-stage renal disease over 25 years in the population-based WESDR cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Companies waver in efforts to target transforming growth factor beta in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

TGF-beta antagonists: why suppress a tumor suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

How cells read TGF-beta signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Blockade of maitotoxin-induced endothelial cell lysis by glycine and L-alanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Pirfenidone in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Pirfenidone improves renal function and fibrosis in the post-obstructed kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Pirfenidone is renoprotective in diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Pirfenidone for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Chemokines and chemokine receptors are involved in the resolution or progression of renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

The endothelin system and its antagonism in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Endothelin antagonism in pulmonary hypertension, heart failure, and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Reduced extracellular pH increases endothelin-1 secretion by human renal microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Transgenic animal models for the analysis of the renal endothelin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Comparison of Endothelin-A and Endothelin-B Receptor Distribution Visualized by Radioligand Binding versus Immunocytochemical Localization using Subtype Selective Antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Regression of renal vascular fibrosis by endothelin receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Avosentan reduces albumin excretion in diabetics with macroalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Avosentan for overt diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Reactive oxygen species: roles in blood pressure and kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Reactive oxygen species in vascular biology: role in arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

ATVB in focus: redox mechanisms in blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

NADPH oxidases: new regulators of old functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Vascular NAD(P)H oxidases: specific features, expression, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Endothelial function and oxidative stress in renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Renal Fibrosis and Glomerulosclerosis in a New Mouse Model of Diabetic Nephropathy and Its Regression by Bone Morphogenic Protein-7 and Advanced Glycation End Product Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Bone Morphogenic Protein-7 Induces Mesenchymal to Epithelial Transition in Adult Renal Fibroblasts and Facilitates Regeneration of Injured Kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Differentiation of cell types in the mammalian kidney by immunofluorescence microscopy using antibodies to intermediate filament proteins and desmoplakins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Endothelial dysfunction in CKD: a new player in town?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Mechanisms of tubulointerstitial fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Reversal of liver fibrosis and cirrhosis--an emerging reality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Endothelial cell chimerism after renal transplantation and vascular rejection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Mechanistic insights into the antifibrotic activity of aliskiren in the kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Chemokines in tumor progression and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Endothelin peptides and receptors in human kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Application of monoclonal antibodies for endothelin to hypertensive research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Late-Onset Endothelin-A Receptor Blockade Reduces Podocyte Injury in Homozygous Ren-2 Rats Despite Severe Hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Role of endothelin as a mitogen in experimental glomerulonephritis in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria: a double-blind, placebo-controlled randomized trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

Oxidative stress in malignant and non-malignant phase hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.14

The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression.

31 March 2020

1 reference

12 December 2020

US Renal Data System 2010 Annual Data Report

1 reference

12 December 2020

Incidence of chronic renal insufficiency. A study of the incidence and pattern of renal insufficiency in adults during 1966-1971 in Gothenburg

1 reference

12 December 2020

Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23-p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin-3 gene (EDN3) to 20q13.2-q13.3

1 reference

12 December 2020

Role of the microvascular endothelium in progressive renal disease.

1 reference

12 December 2020

Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosis

1 reference

12 December 2020

Molecular insights into renal interstitial fibrosis

1 reference

12 December 2020

Early recognition of CKD can delay progression

1 reference

12 December 2020

The effect of vardenafil (a PDE type 5 inhibitor) on renal function in the diabetic rabbit: a pilot study.

1 reference

12 December 2020

Progression of renal insufficiency in pediatric patients: estimation from serum creatinine

1 reference

12 December 2020

Role of fibroblast activation in inducing interstitial fibrosis

1 reference

12 December 2020

Characterization of high endothelial-like properties of peritubular capillary endothelium during acute renal allograft rejection

1 reference

12 December 2020

The disposition and pharmacokinetics in humans of 5-azacytidine administered intravenously as a bolus or by continuous infusion

1 reference

12 December 2020

TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2014.14

1 reference

30 August 2017

1 reference

PubMed ID

24514753